Medicover

Interim Report January-March 2018

STOCKHOLM, April 26, 2018 /PRNewswire/ --

• Revenue increased by 14.1% to €161.9m (€141.9m). Organic revenue grew by 13.3%.
• Operating profit amounted to €8.1m (€6.8m), representing an operating margin of 5.0% (4.8%).
• Net profit amounted to €9.4m (€4.4m), which represents a net profit margin of 5.8% (3.1%).
• Cash flow from operating activities amounted to €6.6m (€8.8m).
• Basic/diluted earnings per share (EPS) was €0.067 (€0.040).
• EBITDA increased by 13.6% to €15.0m (€13.2m), corresponding to an EBITDA margin of 9.3% (9.3%).

REVENUE AND EARNINGS

€ millions (€m)	Q1 2018	Q1 2017	Growth	FY 2017
Revenue	161.9	141.9	14%	580.2
Operating profit	8.1	6.8	19%	28.8
Operating profit margin, %	5.0%	4.8%		5.0%
Net profit	9.4	4.4	114%	20.2
Net profit margin, %	5.8%	3.1%		3.5%
Earnings per share, €